Elutia (ELUT) Income towards Parent Company (2019 - 2026)
Elutia (ELUT) posted Income towards Parent Company of $425000.0 for Q1 2026, down 99.45% sequentially from $77.3 million in Q4 2025, and up 120.77% YoY from $192506.1 in Q1 2025.
Elutia (ELUT) Income towards Parent Company (2019 - 2026) Analysis & Trends
Elutia has reported Income towards Parent Company for 8 years, with the latest figure at $425000.0 in Q1 2026.
- Quarterly Income towards Parent Company rose 120.77% year-over-year to $425000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.6 million (up 1209.55% YoY) and the FY2025 annual result came in at $69.3 million, up 904.87% from the prior year.
- Income towards Parent Company retreated to $425000.0 in Q1 2026 per ELUT's latest filing, from $77.3 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at $77.3 million in Q4 2025 and troughed at -$18.0 million in Q1 2024.
- A 5-year average of $1.7 million and a median of -$1.9 million in 2024 frame the typical range for Income towards Parent Company.
- The widest YoY moves for Income towards Parent Company: up 4155.67% in 2025, down 5438.89% in 2025.
- Over 5 years, Income towards Parent Company stood at $575000.0 in 2022, then jumped by 927.48% to $5.9 million in 2023, then plunged by 132.26% to -$1.9 million in 2024, then soared by 4155.67% to $77.3 million in 2025, then plunged by 99.45% to $425000.0 in 2026.
- According to Business Quant data, Income towards Parent Company over the past three periods registered $425000.0, $77.3 million, and -$3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Elutia | 40.24 Mn | 20.35 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 77.30 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -9.61 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | -1.91 Mn |
| Sep 30, 2024 | -2.05 Mn |
| Jun 30, 2024 | 180,000.00 |
| Mar 31, 2024 | -17.99 Mn |
| Dec 31, 2023 | 5.91 Mn |
| Sep 30, 2023 | -1.23 Mn |
| Jun 30, 2023 | -2.89 Mn |
| Mar 31, 2023 | 1.81 Mn |
| Dec 31, 2022 | 575,000.00 |
| Sep 30, 2022 | 1.12 Mn |
| Jun 30, 2022 | -9.40 Mn |
| Mar 31, 2022 | -8.15 Mn |
| Dec 31, 2021 | -9.06 Mn |
| Sep 30, 2021 | -8.32 Mn |
| Jun 30, 2021 | -2.39 Mn |